Qorvo QRVO CSG — Intangible Asset, Finite-Lived, Impairment Loss
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Qorvo in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.
The source filing: Qorvo’s 10-K, filed May 8, 2026.
- Filed
- May 8, 2026, 4:12 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-032873
In March 2026, due to slower than expected market adoption for certain technologies, the Company revised its forecasts for a reporting unit within the CSG segment and determined it was more likely than not that the fair value of the reporting unit was below its carrying amount, and impairment testing was triggered. The impairment testing resulted in impairments of goodwill and intangible assets (developed technology) of approximately $36.5 million and $45.9 million, respectively. The estimated fair values of the intangible assets and the reporting unit were determined using the income approach, and the significant inputs related to valuing these assets are classified as Level 3 in the fair value hierarchy.
Item 8. Financial Statements and Supplementary Data.
FAQ
- What is Qorvo's CSG — intangible asset, finite-lived, impairment loss?
- Qorvo (QRVO) reported CSG — intangible asset, finite-lived, impairment loss of $45.9M in Q1 2026.
- What does CSG — intangible asset, finite-lived, impairment loss mean?
- The impairment charge taken against finite-lived intangible assets, such as patents, customer relationships, or developed technology, within the CSG segment. It indicates that the asset's carrying value is no longer recoverable through future cash flows.
Ask your AI about Qorvo's csg — intangible asset, finite-lived, impairment loss.
Connect your AI assistant and compare it to peers, right in your chat.
